We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Good question. Mystery stock. Buying at 1.8 few days ago was nt at one point. Few sells at 1.1 and down 17%.must be getting it ready for massive rise:)
why is the spread so insane?
After tax profit before non-controlling interests for the period was USD62.3 million (H1 2019: loss of USD2.8 million)
This is a share that if you know what you are doing and have been tracking them for sometime like we have then tomorrow is going to be beautiful. Well deserved returns in the region of 1,000%. All indications point to a spectacular announcement. Bank holiday is going to be one to remember.
Just read report. Profit up a massive 360%...
The board of directors (the “Board”) of Lansen Pharmaceutical Holdings Limited (the
“Company”) is pleased to announce the unaudited consolidated results of the Company
and its subsidiaries (collectively referred to as “Lansen” or the “Group”) for the six months
ended 30 June 2020 as follows:
CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER
COMPREHENSIVE INCOME
For the six months ended 30 June 2020
Six months
ended
30 June 2020
Six months
ended
30 June 2019
US$’000 US$’000
Notes (unaudited) (unaudited)
Revenue 4 26,776 26,152
Cost of sales (8,848) (10,057)
Gross profit 17,928 16,095
Other income 4 518 1,392
Selling and distribution expenses (6,078) (8,141)
Administrative expenses (6,318) (8,154)
Reversal of /(Allowance for) expected credit
losses on financial assets 134 (519)
Profit from operations 6,184 673
Other non-operating income and expenses 6 98,230 7,755
Write off of derivative financial instrument – (1,910)
Finance costs 7 (1,176) (2,358)
Share of post-tax result of associates 4 1,019
Profit before income tax 8 103,242 5,179
Income tax expense 9 (6,800) (396)
Profit for the period 96,442 4,783
Off we go
Remember results in morning. Don't miss out on the re rate :)
I’m looking forward to the results on Friday. Looking forward to a nice return.
Nice uplift to results on 28th
Net Assets Value and Gearing
The Group’s net assets at 31 December 2019 were USD92.0 million (2018: USD117.1 million). Net assets per share at 31 December 2019 were USD 0.24; GBP 0.18 (2018: USD0.31).
The Group’s cost of investment in Starry was USD 9.2 million under the equity accounting basis. Based on Starry’s closing price on 31 December 2019, the market value of the investment in Starry was approximately USD 40.9 million.
The difference between the book value and the market value of Starry was not included in the consolidated financial statements.
NAV not reflected in SP, or disposal, hoping for updates this week.
The question is. where is all this cash heading. New investment?new sector?
Cash from starry sale plus massive raise at 1.5p. Cash in bank must be £50m plus....hhhmm some warchest...
Should have had further updates by now, cash return is substantial.
A look. Strong pharma connections. Plenty of cash in war chest.. Crazy low prices.
Disposal of Starry Shares
Hong Kong, 23 July 2020 - Cathay International Holdings Limited (LSE: CTI.L) , an operator and investor in the growing healthcare sector in the People's Republic of China, announces that further to the approvals granted by Cathay's shareholders on 15 May 2020 and by the shareholders of its subsidiary, Lansen Pharmaceutical Holdings Limited (Lansen) (HKEX: 503), on 13 July 2020, Lansen has further disposed on-market of an aggregate of 424,000 shares in Zheijang Starry Pharmaceutical Co., Ltd (Starry) at the price of RMB 78.10 per Starry Shares on 23 July 2020. The selling price of RMB 78.10 represented 6 per cent discount to the closing price of Starry Shares on the Shanghai Stock Exchange on 22 July 2020 .
The gross sale proceeds of disposal were approximately RMB33.11 million and, after deducting transaction costs and related tax, expected to be approximately RMB31.18 million (approximately US$4.46 million). Lansen is expected to recognise a net gain of approximately USD 3.96 million, of which USD 2.09 million is attributable to Cathay. The above-mentioned US$ amounts are converted based on the exchange rate of US$1=RMB6.9921, and the actual exchange rate used in conversion may be different.
As at the date of this announcement after the disposal of Starry Shares, 4,718,855 Shares are owned by the Lansen group (representing approximately 2.01% in Starry), which value will be subject to market price fluctuations.
Thats USD 22.58 receivable and another usd 25 soon.
Cathay International Holdings Limited
("Cathay" or the "Company")
TRANSFER OF LISTING
Hong Kong, 14 July 2020 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China , today announces that following the passing of a special resolution by its shareholders at the Company's general meeting held on 15 June 2020, the Company's listing category has been transferred from "premium listing (commercial company)" to "standard listing",
Seemed intent on keeping their listing.
Disposal of Starry Shares
Hong Kong, 22 July 2020 - Cathay International Holdings Limited (LSE: CTI.L) , an operator and investor in the growing healthcare sector in the People's Republic of China, announces that further to the approvals granted by Cathay's shareholders on 15 May 2020 and by the shareholders of its subsidiary, Lansen Pharmaceutical Holdings Limited (Lansen) (HKEX: 503), on 13 July 2020, Lansen has further disposed on-market of an aggregate of 1,910,000 shares in Zheijang Starry Pharmaceutical Co., Ltd (Starry) at the price of RMB 73.75 per Starry Shares on 22 July 2020. The selling price of RMB 73.75 represented 3 per cent discount to the closing price of Starry Shares on the Shanghai Stock Exchange on 21 July 2020 .
The gross sale proceeds of disposal were approximately RMB140.86 million and, after deducting transaction costs and related tax, expected to be approximately RMB132.66 million (approximately US$19.03 million). Lansen is expected to recognise a net gain of approximately USD 16.8 million, of which USD 8.9 million is attributable to Cathay. The above-mentioned US$ amounts are converted based on the exchange rate of US$1=RMB6.9718, and the actual exchange rate used in conversion may be different.
As at the date of this announcement after the disposal of Starry Shares, 5,142,855 Shares are owned by the Lansen group (representing approximately 2.19% in Starry), which value will be subject to market price fluctuations.
Thats 20.49m to CTI so far, and more of the same to come. Selling slowly on hongkong market so as not to drop the price
This is gonna get motoring soon. Ridiculous spread, way oversold. And now plenty of cash in bank..
What happened at Sealand?
The disposals have been missed by Mr Market. Cathy just handed plenty of cash. Interesting developments here
Fri, 17th Jul 2020 12:12
RNS Number : 3779T
Cathay International Holdings Ld
17 July 2020
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).
Cathay International Holdings Limited ("Cathay" or the "Company")
Disposal of Starry Shares
Hong Kong, 17 July 2020 - Cathay International Holdings Limited (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China, announces that further to the approvals granted by Cathay's shareholders on 15 May 2020 and by the shareholders of its subsidiary, Lansen Pharmaceutical Holdings Limited (Lansen) (HKEX: 503), on 13 July 2020, Lansen has disposed on-market of an aggregate of 2,349,505 shares in Zheijang Starry Pharmaceutical Co., Ltd (Starry) at an average price of RMB 78.97 per Starry Shares during the period from 14 July 2020 up to 17 July 2020.
The gross sale proceeds of disposal were approximately RMB185.55 million and, after deducting transaction costs and related tax, expected to be approximately RMB174.68 million (approximately US$24.67 million). Lansen is expected to recognise a net gain of approximately USD 21.93 million, of which USD 11.59 million is attributable to Cathay. The above-mentioned US$ amounts are converted based on the exchange rate of US$1=RMB7.0795, and the actual exchange rate used in conversion may be different.
As at the date of this announcement after the disposal of Starry Shares, 7,052,855 Shares are owned by the Lansen group (representing 3% in Starry), which value will be subject to market price fluctuations.
The full text of the Lansen Announcement can be found at https://www1.hkexnews.hk/listedco/listconews/sehk/2020/0717/2020071701148.pdf and will also be made available at the Announcements & Notices section of Lansen's homepage at http://holding.lansen.com.cn/en/newslist.aspx?NodeCode=10002000700050005.
- ENDS -
Cathay International Holdings Ld (CTI London Stock Exchange)
CTI London 51% holder.
LANSEN PHARMACEUTICAL HOLDINGS LIMITED
POSSIBLE VERY SUBSTANTIAL DISPOSAL: DISPOSAL OF LISTED SECURITIES OF ZHEJIANG STARRY PHARMACEUTICAL CO., LTD. AND NOTICE OF EXTRAORDINARY GENERAL MEETING
The Group’s audited book cost of investment in Starry of approximately RMB 64,020,000 as at 31 December 2019.
The audited net asset value of Starry as at 31 December 2019 and unaudited net asset value of Starry as at 31 March 2020 is approximately RMB 1,028,707,000 and RMB 1,079,275,000.
Nearly 20 fold return imminent on there investment.
DYOR
free fall here
Downes is a very experienced stock broker and has been around for a long time. He is also a shrewd investor. Good to see him topping up his holding yesterday.